Connection
James Falko to Anticholesteremic Agents
This is a "connection" page, showing publications James Falko has written about Anticholesteremic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.520 |
|
|
|
-
Allian-Sauer MU, Falko JM. New treatments on the horizon for familial hypercholesterolemia. Expert Rev Cardiovasc Ther. 2012 Oct; 10(10):1227-37.
Score: 0.362
-
Snow R, LaLonde M, Hindman L, Falko J, Caulin-Glaser T. Independent effect of cardiac rehabilitation on lipids in coronary artery disease. J Cardiopulm Rehabil. 2005 Sep-Oct; 25(5):257-61; quiz 262-3.
Score: 0.055
-
Falko JM, Moser RJ, Meis SB, Caulin-Glaser T. Cardiovascular disease risk of type 2 diabetes mellitus and metabolic syndrome: focus on aggressive management of dyslipidemia. Curr Diabetes Rev. 2005 May; 1(2):127-35.
Score: 0.054
-
Cottrell DA, Marshall BJ, Falko JM. Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome. Curr Opin Cardiol. 2003 Jul; 18(4):301-8.
Score: 0.048